Showing 1 - 10 of 129,997
Ind ividual moral hazard engendered by health insurance and monopolistic production are both typical phenomena of drug markets. We develop a simple model containing these two elements and evaluate the market equilibrium on the basis of consumer and social welfare. The consumer welfare criterion...
Persistent link: https://www.econbiz.de/10001745192
copayments (specific reimbursements). We show that the induced equilibrium with copayments involves a lower producer price and a … higher level of welfare for consumers. This results provides strong support for a reference price based reimbursement policy. …
Persistent link: https://www.econbiz.de/10012581345
Persistent link: https://www.econbiz.de/10012542707
Persistent link: https://www.econbiz.de/10011963838
our theory is the health care market, where drug prices can be very high. Our model predicts that monopoly prices for …We offer a theory of how the combination of budget constraints and insurance drives up prices. A natural context for … orphan drugs are inversely related to the prevalence up until a maximum price. This is supported by empirical evidence in the …
Persistent link: https://www.econbiz.de/10012416335
-of-pocket drug costs decrease substantially. Our results suggest an average price elasticity of -0.17, which indicates evident moral …
Persistent link: https://www.econbiz.de/10014289803
Persistent link: https://www.econbiz.de/10003419013
Persistent link: https://www.econbiz.de/10011869307
We analyze individuals with heterogeneous time-inconsistent preferences that consume sin goods and make a savings decision. A government may tax the sin good and provide mandatory health insurance. Due to time-inconsistency, the individual sin good and savings choices in ict internalities. Due...
Persistent link: https://www.econbiz.de/10012312290